Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases

This study has been terminated.
Information provided by:
Central European Cooperative Oncology Group Identifier:
First received: February 20, 2006
Last updated: April 30, 2012
Last verified: April 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2007
  Primary Completion Date: December 2003 (Final data collection date for primary outcome measure)